128 related articles for article (PubMed ID: 27540539)
1. The effect of the various doses of atorvastatin on renal tubular cells; an experimental study.
Nasri H; Hasanpour Z; Nematbakhsh M; Ahmadi A; Rafieian-Kopaei M
J Nephropathol; 2016 Jul; 5(3):111-5. PubMed ID: 27540539
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical effects of atorvastatin on renal tubular cells: an experimental investigation.
Hasanpour Z; Nasri H; Rafieian-Kopaei M; Ahmadi A; Baradaran A; Nasri P; Nematbakhsh M
Iran J Kidney Dis; 2015 May; 9(3):215-20. PubMed ID: 25957426
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin attenuates experimental contrast-induced acute kidney injury: a role for TLR4/MyD88 signaling pathway.
Yue R; Zuo C; Zeng J; Su B; Tao Y; Huang S; Zeng R
Ren Fail; 2017 Nov; 39(1):643-651. PubMed ID: 28805489
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin inhibits renal crystal retention in a rat stone forming model.
Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction.
Mizuguchi Y; Miyajima A; Kosaka T; Asano T; Asano T; Hayakawa M
J Urol; 2004 Dec; 172(6 Pt 1):2456-9. PubMed ID: 15538290
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin ameliorates contrast medium-induced renal tubular cell apoptosis in diabetic rats via suppression of Rho-kinase pathway.
Su J; Zou W; Cai W; Chen X; Wang F; Li S; Ma W; Cao Y
Eur J Pharmacol; 2014 Jan; 723():15-22. PubMed ID: 24445019
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin ameliorates genetamicin-induced renal toxicity: A biochemical and histopathological study.
Rafieian-Kopaei M; Nasri H; Nematbakhsh M; Baradaran A; Gheissari A; Rouhi H; Ahmadi Soleimani SM; Baradaran-Ghahfarokhi M; Ghaed-Amini F; Ardalan M
J Nephropathol; 2012 Jul; 1(2):109-16. PubMed ID: 24475398
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin donor pretreatment prevents ischemia/reperfusion injury in renal transplantation in rats: possible role for aldose-reductase inhibition.
Gottmann U; Brinkkoetter PT; Hoeger S; Gutermann K; Coutinho ZM; Ruf T; Hui S; Liu Z; Schnuelle P; van der Woude FJ; Braun C; Yard BA
Transplantation; 2007 Sep; 84(6):755-62. PubMed ID: 17893609
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
12. [Atorvastatin attenuated contrast induced renal function damage].
Chen GL; Su JZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 May; 37(5):389-93. PubMed ID: 19781210
[TBL] [Abstract][Full Text] [Related]
13. Fertility and general reproduction studies in rats with the HMG-CoA reductase inhibitor, atorvastatin.
Dostal LA; Whitfield LR; Anderson JA
Fundam Appl Toxicol; 1996 Aug; 32(2):285-92. PubMed ID: 8921332
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin attenuates contrast-induced nephropathy by modulating inflammatory responses through the regulation of JNK/p38/Hsp27 expression.
He X; Li L; Tan H; Chen J; Zhou Y
J Pharmacol Sci; 2016 May; 131(1):18-27. PubMed ID: 27156929
[TBL] [Abstract][Full Text] [Related]
15. Long Term Study of Protective Mechanisms of Human Adipose Derived Mesenchymal Stem Cells on Cisplatin Induced Kidney injury in Sprague-Dawley Rats.
Elhusseini FM; Saad MA; Anber N; Elghannam D; Sobh MA; Alsayed A; El-Dusoky S; Sheashaa H; Abdel-Ghaffar H; Sobh M
J Stem Cells Regen Med; 2016; 12(1):36-48. PubMed ID: 27398000
[TBL] [Abstract][Full Text] [Related]
16. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ
JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of N-acetylcystein and atorvastatin against renal and hepatic injury in a rat model of intestinal ischemia-reperfusion.
Alexandropoulos D; Bazigos GV; Doulamis IP; Tzani A; Konstantopoulos P; Tragotsalou N; Kondi-Pafiti A; Kotsis T; Arkadopoulos N; Smyrniotis V; Perrea DN
Biomed Pharmacother; 2017 May; 89():673-680. PubMed ID: 28273631
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of Renal Inflammation, Endoplasmic Reticulum Stress and Apoptosis Underlies the Protective Effect of Low Dosage of Atorvastatin in Gentamicin-Induced Nephrotoxicity.
Jaikumkao K; Pongchaidecha A; Thongnak LO; Wanchai K; Arjinajarn P; Chatsudthipong V; Chattipakorn N; Lungkaphin A
PLoS One; 2016; 11(10):e0164528. PubMed ID: 27727327
[TBL] [Abstract][Full Text] [Related]
19. The reno-protective effects of atorvastatin in crush syndrome and rhabdomyolysis:is there a dilemma?
Acar D; Gülpembe M; Yıldız CG; Özdamar EN; Açıkgöz K; Çağlar A; Cander B
Turk J Med Sci; 2017 Dec; 47(6):1920-1924. PubMed ID: 29306258
[TBL] [Abstract][Full Text] [Related]
20. Effect of atorvastatin on IgA nephropathy in the rat.
Katzir Z; Leibovitch E; Vaknin H; Schreiber L; Berger E; Matas Z; Fux A; Boaz M; Briliant A; Biro A
Clin Nephrol; 2013 Mar; 79(3):214-20. PubMed ID: 23073067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
